ELK1 and breast cancer: Based on the aforementioned research, this study was initiated with the purpose to explore the regulatory mechanism of circRNA hsa_circRPPH1_015/miR-326/ELK1 in BC which may provide a novel biomarker to enhance the clinical efficacy of BC treatment.